
Press Releases & Clinical Resources
PRESS RELEASES

February 15, 2024
FDA acceptance of double blind, randomized, placebo controlled Clinical Trial for Long Covid

April 10, 2024
PeploBio and IncellDX partner to launch the First Long COVID test in the UK and EU
CLINICAL RESOURCES
.png)
CLINICAL STUDY
Long COVID Diagnostic with Differentiation from Chronic Lyme Disease using Machine Learning and Cytokine Hubs

CLINICAL STUDY
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

NIH NATIONAL LIBRARY
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning

CLINICAL STUDY
Case Series: Maraviroc and Pravastatin as a Therapeutic Option to treat Long Covid/Post-Acute Sequelae of Covid (PASC)
Contact Us
Please be specific with your questions and one of our
team members will get back to you as soon as possible.
team members will get back to you as soon as possible.
.png)